Predominant sensory ataxic neuronopathy showing marked improvement after resection of a thymoma followed by intravenous immunoglobulin therapy.

A 64-year-old man was admitted to our hospital because of difficulty in walking and numbness in his lower extremities. Upon investigation, the patient was diagnosed as having predominant sensory ataxic neuronopathy associated with thymoma. Surgical resection of the thymoma followed by intravenous immunoglobulin therapy resulted in marked improvement of the patient's clinical symptoms; therefore immunological mechanisms related to the presence of the thymoma were suspected to underlie the neuropathy in this patient. We did not find any previous reports of an association of sensory ataxic neuronopathy with thymoma, even after a thorough search of the literature.

[1]  S. Kusunoki,et al.  [Neuropathy associated with paraneoplastic neurological syndrome]. , 2010, Brain and nerve = Shinkei kenkyu no shinpo.

[2]  J. Honnorat,et al.  Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[3]  M. Hashimoto.  [An autopsy case of peripheral neuropathy, complicated by status eplilepticus, associated with high titer of anti-VGKC antibodies]. , 2007, Brain and nerve = Shinkei kenkyu no shinpo.

[4]  V. Lennon,et al.  Autoantibody Profiles and Neurological Correlations of Thymoma , 2004, Clinical Cancer Research.

[5]  J. Greenlee.  Recommended diagnostic criteria for paraneoplastic neurological syndromes , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[6]  J. Antoine,et al.  Are the “newly discovered” paraneoplastic anti‐collapsin response‐mediator protein 5 antibodies simply anti‐cv2 antibodies? , 2001, Annals of neurology.

[7]  G. Escaramís,et al.  Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. , 2001, Brain : a journal of neurology.

[8]  E. Benarroch,et al.  CRMP‐5 neuronal autoantibody: Marker of lung cancer and thymoma‐related autoimmunity , 2001, Annals of neurology.

[9]  L. Sobin,et al.  Histological Typing of Tumours of the Thymus , 1999, World Health Organization. International Histological Classification of Tumours.

[10]  F. Heidenreich,et al.  Antibodies to ion-channel proteins in thymoma with myasthenia, neuromyotonia, and peripheral neuropathy , 1998, Neurology.

[11]  J. Honnorat,et al.  Antibodies to a subpopulation of glial cells and a 66 kDa developmental protein in patients with paraneoplastic neurological syndromes. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[12]  E. Rosenow,et al.  Disorders of the thymus. A review. , 1984, Archives of internal medicine.